potential of g-csf supplementation to counter the neutrophil effects of standard peg-ifnα plus ribavirin combination therapy for treating hcv-related cirrhosis

Clicks: 336
ID: 251765
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 78 articles by views in lontar komputer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ObjectiveTo investigate the effects of the granulocyte colony stimulating factor (G-CSF) with pegylated interferon alpha (PEG-IFNα) plus ribavirin(RBV) and PEG-IFNα reduction in the treatment of the compensatory hepatitis C virus(HCV)-related cirrhosis . MethodsFourty-eight patients with compensatory HCV-related liver cirrhosis were devided into two groups: G-CSF with PEG-IFNα plus RBV and PEG-IFNα reduction. Another 28 patients who received standardized anti-virus therapy were taken as the control group. The rapid viral response (RVR), early virologic response (EVR), end-treatment virologic response (ETVR), sustained viral response (SVR) and recurrence after withdrawal were observed in the following 48 weeks. In addition, the recovery of liver function adverse reactions were recorded. Intergroup differences were assessed by ANOVA or Chi-squared test. ResultsThe rates of ETVR and SVR in GM-CSF with PEG-IFNα plus ribavirin group between standardized anti-virus therapy group was not statistically significant(P＞005). But the rates of ETVR and SVR in PEG-IFNα reduction group were lower than standardized anti-virus therapy group, and the difference was statistically significant(χ2=8266、4467，P＜005). The rates of ETVR and SVR in GM-CSF with PEG-IFNα plus ribavirin group were higher than PEG-IFNα reduction group, but lower than the latter in the rate of recurrence. The difference was statistically significant (χ2=4009,P＜005). ConclusionG-CSF with PEG-IFNα plus RBV was better than PEG-IFNα reduction in the treatment of compensated HCV-related liver cirrhosis.
Reference Key
sumei2013linchuangpotential Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;ZHANG Sumei
Journal lontar komputer
Year 2013
DOI
DOI not found
URL
http://www.lcgdbzz.org/qk_content.asp?id=5345&ClassID=5416634
Keywords
hepatitis c chronic liver cirrhosis granulocyte colony-stimulating factor ribavirin Gastroenterology interferon alfa-2adiseases of the digestive system

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.